CNS Pharmaceuticals to Present at 6th Glioblastoma Drug Development Summit
HOUSTON, TX / ACCESS Newswire / February 18, 2025 / CNS Pharmaceuticals, Inc. (NASDAQ:CNSP)("CNS" or the "Company"), a ...